Skip to content

Clinical Outcomes of Low Versus Versus High Intensity Laser Therapy in the Treatment of Patients with Subacute Carpal Tunnel Syndrome

Clinical Outcomes of Low Versus Versus High Intensity Laser Therapy in the Treatment of Patients with Subacute Carpal Tunnel Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241111063665N1
Enrollment
69
Registered
2025-03-17
Start date
2024-08-29
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacute Carpal Tunnel Syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: A High-Intensity Laser Therapy + Physical Therapy Participants in Group A will receive High-Intensity Laser Therapy combined with P

Sponsors

self
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age of participants 20-40 years Individuals who have been diagnosed with carpal tunnel syndrome, regardless of gender Based on electromyography-nerve conduction velocity (EMG-NCV) investigation, the diagnosis of mild carpal tunnel syndrome was confirmed. This involves the involvement of both sensory and motor fibers to the extent that none are absent, with a sensory and motor delay of more than 3.6 msec and 4.1 msec, respectively.

Exclusion criteria

Exclusion criteria: According to an EMG-NCV investigation, there are patients with mild (sensory nerve latency >3.5 ms at third digit) and severe (missing sensory or motor waves) CTS. Patients with a history of continuous physical therapy or exercise during the previous two weeks, or taking analgesic or anti-inflammatory drugs during the week before the baseline assessment. Hypothyroidism Cancer Active infection Pulmonary disease Acquired immunodeficiency syndrome Associated Myopathy Myelopathy History of neck and/or shoulder surgery, drug abuse, corticosteroid consumption, and high-risk pregnancy

Design outcomes

Primary

MeasureTime frame
Ultrasound changes. Timepoint: Before intervention and after 5 weeks of Intervention. Method of measurement: Ultrasound.;CMAP and SNAP latencies. Timepoint: Before intervention and after 5 weeks of Intervention. Method of measurement: Nerve Conduction Studies.

Secondary

MeasureTime frame
Pain. Timepoint: Before intervention and after 5 weeks of Intervention. Method of measurement: Visual Analogue Scale.;Electrophysiological Changes. Timepoint: Before intervention and after 5 weeks of Intervention. Method of measurement: Nerve Conduction Studies and EMG.;Hand Grip/ Strength. Timepoint: Before intervention and after 5 weeks of Intervention. Method of measurement: Handheld Dynamometer.;Quality of Life. Timepoint: Before intervention and after 5 weeks of Intervention. Method of measurement: Quality of Life Scale.;Hand Function. Timepoint: Before intervention and after 5 weeks of Intervention. Method of measurement: SF-36.

Countries

Pakistan

Contacts

Public ContactArif Ali Rana

University of Lahore

Arifalirana@gmail.com+92 42 34500003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026